Gazing into a crystal ball–cancer therapy in the post-genomic era
暂无分享,去创建一个
[1] M. Daly,et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms , 2001, Nature.
[2] P. Deloukas,et al. Comparison of human genetic and sequence-based physical maps , 2001, Nature.
[3] J. V. Moran,et al. Initial sequencing and analysis of the human genome. , 2001, Nature.
[4] D. Haussler,et al. Integration of cytogenetic landmarks into the draft sequence of the human genome , 2001, Nature.
[5] E. Birney,et al. Cancer and genomics , 2001, Nature.
[6] C. Harris,et al. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] M. Relling,et al. Pharmacogenomics: translating functional genomics into rational therapeutics. , 1999, Science.
[8] F. Collins,et al. Shattuck lecture--medical and societal consequences of the Human Genome Project. , 1999, The New England journal of medicine.
[9] J. Rowley. A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining , 1973, Nature.
[10] W. J. Spillman. INHERITANCE OF COLOR COAT IN SWINE. , 1906, Science.
[11] B. Druker,et al. Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia. , 2000, The Journal of clinical investigation.